Mapping of IgG subclass and T-cell epitopes on HIV proteins by synthetic peptides. NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Mapping of IgG subclass and T-cell epitopes on HIV proteins by synthetic peptides.

Immunology. 1989 Aug;67(4):453-9. Unique Identifier : AIDSLINE MED/89358077
Mathiesen T; Broliden PA; Rosen J; Wahren B; National Bacteriological Laboratory, Karolinska Institute,; Stockholm, Sweden.

Abstract: Fifteen amino acid peptides, sequentially overlapping by 10 amino acids, were synthesized on the basis of the HTLV-III sequences of the gag and env proteins. They were used as antigens in IgG subclass ELISAs and T-cell stimulation assays. Sera and cells were obtained from 30 asymptomatic, HIV-infected homosexuals. In all subclasses reactivity was found to parts of the gag protein, while IgG1 dominated anti-env peptide responses. It was possible to delineate peptides showing restricted IgG subclass responses that were dominated by either IgG1, 2, 3 or 4. A negative correlation was generally observed between B-cell and T-cell reactivity, but a T-cell and B-cell co-operation was suggested by the response to two IgG1-restricted peptides. The IgG3-dominated epitopes were present in peptides previously known to be amphipathic and capable of T-cell stimulation. The analysis of subclass-restricted responses on the peptide level will assist the understanding of the subclass expression in vivo, since the peptide mapping approximates the delineation of a subclass-restricted response at the level of single epitopes.
Keywords: Epitopes/*IMMUNOLOGY Human HIV/*IMMUNOLOGY HIV Antigens/IMMUNOLOGY IgG/*CLASSIFICATION Peptide Mapping Retroviridae Proteins/*IMMUNOLOGY T-Lymphocytes/*IMMUNOLOGY Viral Envelope Proteins/IMMUNOLOGY JOURNAL ARTICLEKWDepitopes/KWDimmunologyhumanhiv/KWDimmunologyhivantigens/immunologyigg/KWDclassificationpeptidemappingretroviridaeproteins/KWDimmunologyt-lymphocytes/KWDimmunologyviralenvelopeproteins/immunologyjournalarticle
891230
M89C0023

Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .